INOVIO Pharmaceuticals
NEWS ALERT

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Press Releases

INOVIO Announces Proposed Public Offering

Posted on November 10, 2025

INOVIO Announces Proposed Public Offering

Posted on November 10, 2025

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Posted on November 10, 2025

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Posted on November 10, 2025

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Posted on November 3, 2025

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Posted on November 3, 2025

INOVIO Reports Inducement Grant Under Inducement Plan

Posted on October 31, 2025

INOVIO Reports Inducement Grant Under Inducement Plan

Posted on October 31, 2025

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Posted on October 27, 2025

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Posted on October 27, 2025

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.